Non-Oncology Next Generation Sequencing

I would like to better understand the market for next-generation sequencing services in non-oncology applications. In particular, I would like to speak with biopharma professionals in the space of neurology (focus on neurodegenerative disorders, multiple sclerosis, rare neuromuscular disorders), endocrinology (focus on MASH and obesity) and cardiology (focus on cardiomyopathy) to hear their perspectives on the topic. Ideally, I would like to discuss clinical development of NGS-based assays or studies and the evaluation/purchasing of external sequencing services.

Apply for Consideration

Refer Someone